Clinical, genetic, and brain imaging predictors of risk for bipolar disorder in high-risk individuals. (3rd March 2020)

• Record Type: Journal Article
• Authors: Steardo Jr, Luca; Manchia, Mirko; Carpiniello, Bernardo; Pisanu, Claudia; Steardo, Luca; Squassina, Alessio
• Is Part Of: Expert review of molecular diagnostics. Volume 20:Number 3(2020)
• Page Start: 327
• Page End: 333
• Publication Date: 2020-03-03
• Subjects: Biomarker -- early intervention -- genetics -- longitudinal -- mood disorders -- neuroimaging -- offspring -- staging -- ultra-high risk; Molecular diagnosis -- Periodicals; 616.0758205
• DOI: 10.1080/14737159.2020.1727743
• Languages: English
• ISSNs: 1473-7159

Abstract

ABSTRACT: Introduction : Early detection and intervention in bipolar disorder (BD) might reduce illness severity, slow its progression, and, in specific cases, even ward off the full-blown disorder. Therefore, identifying at-risk individuals and targeting them promptly before the illness onset is of the utmost importance. In the last decades, there has been a significant effort aimed at identifying genetic and molecular factors able to modulate risk and pharmacological outcomes. Areas covered : We performed a narrative review of articles aimed at identifying clinical, genetics, molecular, and brain imaging markers of BD specifically focusing on samples of individuals at high-risk for BD. Special emphasis was put on studies applying an integrative design, e.g. studies combining different markers such as genetic and brain imaging. Expert opinion : Findings from studies in risk individuals are still too sparse to allow drawing definite conclusions. However, the high potentiality of longitudinal studies in individuals considered at risk to develop BD supports the need for more efforts. Future investigations should focus on more homogeneous subpopulations and evaluate the cross-linking between clinical, genetic, and brain morphostructural/functional neuroimaging characteristics as predictors of risk for BD.